Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Initiatives
-
Genomic data and its application to clinical use, molecular tumor boards with diverse expertise can provide guidance to oncologists and patients seeking to implement personalized genetically targeted therapy in practice.
- Start Year
- 2013
- End Year
- 2016
- Funding
- National Cancer Institute Grant No. P30 CA006973 to the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Visit Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Investigators | Contacts |
---|---|
|
Design
- Study design
- Patients' cohort
- Follow Up
- A median follow-up of 7 months
Marker Paper
Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. JCO Precis Oncol. 2017;2017:PO.16.00046. doi: 10.1200/PO.16.00046. Epub 2017 May 31.
PUBMED 30003184
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 155
- Number of participants with biosamples
Access
Availability of data and biosamples
Data | |
Biosamples | |
Other |